Dr. Michael Severino is Vice Chairman and President, responsible for
research and development, corporate strategy office, operations and
human resources. He previously served as Executive Vice President,
Research & Development and Chief Scientific Officer of AbbVie.
Prior to joining AbbVie in 2014, Dr. Severino was Senior Vice
President, Global Development and Chief Medical Officer at Amgen, Inc.
During his time at Amgen, he served in roles of increasing
responsibility across a broad range of therapeutic areas including
oncology, inflammation, neuroscience, cardiovascular and metabolic disorders.
Dr. Severino serves on the Board of Directors for Avantor and the
Board of Trustees for the Field Museum. At AbbVie, he is the executive
chair of the Black Business Network Employee Resource Group.
He earned a bachelor’s degree in biochemistry from the University of
Maryland, College Park and a doctorate in medicine from The Johns
Hopkins University in Baltimore, Maryland, U.S.A. Dr. Severino
completed his residency and fellowship training at the Massachusetts
General Hospital and Harvard Medical School in Boston, Massachusetts, U.S.A.